Genetics of Alzheimer's disease: new evidences for an old hypothesis?
- PMID: 21371880
- DOI: 10.1016/j.gde.2011.02.002
Genetics of Alzheimer's disease: new evidences for an old hypothesis?
Abstract
Alzheimer's disease (AD) is the prime cause of dementia and presents a strong genetic predisposition (60-80% of the attributable risk). In addition to APOE, a major recognized genetic determinant of AD, systematic, high-throughput genomic approaches have recently allowed the characterization of four new genetic determinants: CLU, CR1, PICALM and BIN1. Even if the complete picture of AD genetics is still not fully understood, the characterization of these new AD genetic determinants is probably going to strongly modify our perception of the pathophysiological process involved in AD. The new AD genetic landscape suggests that the common and late-onset forms of the disease are associated with a defect in peripheral Aβ peptide clearance, implying that the amyloid cascade hypothesis could be relevant not only in the AD monogenic forms.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Relationship between genetic risk factors and markers for Alzheimer's disease pathology.Biomark Med. 2012 Aug;6(4):477-95. doi: 10.2217/bmm.12.56. Biomark Med. 2012. PMID: 22917148 Review.
-
APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.Neurosci Lett. 2010 Oct 11;483(2):96-100. doi: 10.1016/j.neulet.2010.07.066. Epub 2010 Jul 30. Neurosci Lett. 2010. PMID: 20674675 Review.
-
Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease.PLoS One. 2011 Feb 9;6(2):e15918. doi: 10.1371/journal.pone.0015918. PLoS One. 2011. PMID: 21347408 Free PMC article.
-
Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease.Biochim Biophys Acta. 2010 Aug;1801(8):754-61. doi: 10.1016/j.bbalip.2010.04.005. Epub 2010 Apr 24. Biochim Biophys Acta. 2010. PMID: 20420935 Review.
-
Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.Neurology. 2012 May 8;78(19):1464-71. doi: 10.1212/WNL.0b013e3182553c48. Epub 2012 Apr 25. Neurology. 2012. PMID: 22539578 Free PMC article.
Cited by
-
CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease.J Neurol. 2013 Jul;260(7):1701-8. doi: 10.1007/s00415-012-6690-4. Epub 2012 Oct 16. J Neurol. 2013. PMID: 23070465 Review.
-
Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy.Int J Alzheimers Dis. 2012;2012:630182. doi: 10.1155/2012/630182. Epub 2012 Mar 8. Int J Alzheimers Dis. 2012. PMID: 22482074 Free PMC article.
-
The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases.J Biol Chem. 2016 Feb 26;291(9):4334-41. doi: 10.1074/jbc.R115.704981. Epub 2015 Dec 22. J Biol Chem. 2016. PMID: 26694609 Free PMC article. Review.
-
Mitochondrial alterations in fibroblasts from sporadic Alzheimer's disease (AD) patients correlate with AD-related clinical hallmarks.Acta Neuropathol Commun. 2024 Jun 8;12(1):90. doi: 10.1186/s40478-024-01807-x. Acta Neuropathol Commun. 2024. PMID: 38851733 Free PMC article.
-
Alzheimer's disease: a clinical practice-oriented review.Front Neurol. 2012 Apr 20;3:63. doi: 10.3389/fneur.2012.00063. eCollection 2012. Front Neurol. 2012. PMID: 22529838 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous